Loading...
Found 67 hematology trials
A listing of hematology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
To determine if blood biomarkers are associated with the development of cancer or cancer recurrence or the development of late effects of interventions to decrease cancer risk (such as prophylactic oophorectomy) in individuals at high risk for the development of breast, ovarian, pancreatic and other cancers based on family history …
This study investigates the long-term safety and efficacy of patients who have undergone CAR-T cell therapy. The purpose of this study is to monitor these patients for 15 years following their last CAR-T infusion to assess any delayed adverse events, check for replication competent lentivirus, and evaluate long-term efficacy, including …
This study investigates the presence of disseminated tumor cells (DTCs) in women who have completed treatment for primary breast cancer within the last five years and are at increased risk of relapse. The purpose is to identify markers that could indicate the likelihood of breast cancer returning. This study will …
This study's primary objective will be to create a database of lung cancer patients treated with immunotherapy agents and to access Remnant (left-over) tissue collected from clinically-indicated procedures/surgery for analyses, to determine factors that predict response to immunotherapy, and/or the toxicity prole of patients treated with immunotherapy.
Please refer to Section 6 of the full protocol (Study Objectives). Please refer to Section 12 of the full protocol (Statistical Analysis). Please refer to Section 12 of the full protocol (Statistical Analysis).
This study investigates Li-Fraumeni Syndrome (LFS) and Li-Fraumeni-like (LFL) Syndrome, focusing on the increased cancer risk associated with changes in the TP53 gene. The purpose of this study is to collect and analyze clinical data and biological samples from patients with these conditions to better understand the relationship between genetic …
Please refer to Section 6 of the full protocol (Study Objectives). Please refer to Section 13 of the full protocol (Statistical Analysis). Please refer to Section 13 of the full protocol (Statistical Analysis).
See Section 2.1 See section 5.1 See section 5.1
To investigate the possible re-activation of CAR T-cells in response to interventions subsequent to CAR T-cell infusion.
To investigate immunologic changes in Hodgkin Lymphoma patients treated with itacitinib (a JAK inhibitor) in combination with everolimus (an mTOR inhibitor).
Please choose between Voice or SMS based delivery of verification code
or